![](/img/cover-not-exists.png)
Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Patients Co-Infected with HCV and HIV-1: The Phase 3 Astral-5 Study
Wyles, D., Brau, N., Kottilil, S., Daar, E., Workowski, K., Luetkemeyer, A., Adeyemi, O., Ruane, P., Doehle, B., Huang, K.c, Osinusi, A., McNally, J., Brainard, D., McHutchison, J., Naggie, S., SulkowVolume:
64
Year:
2016
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(16)00129-x
File:
PDF, 119 KB
english, 2016